Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO-169 vs Ranibizumab for Diabetic Macular Edema
NCT05217680Phase 3Completed
- Sponsor
- Laboratorios Sophia
- Start
- May 2021
- Primary completion
- Aug 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in diabetic macular edema (DME), sponsored by Laboratorios Sophia. Started May 2021; status: completed.
02
Drugs
bevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT05217680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05217680.